Tyra Biosciences to Present Groundbreaking Research at 2026 ASCO GU Symposium Tyra Biosciences, a leading biotechnology firm, will showcase its innovative research at the 2026 ASCO Genitourinary Cancers Symposium in San Francisco.

Tyra Biosciences to Present Groundbreaking Research at 2026 ASCO GU Symposium #United_States #San_Francisco #Tyra_Biosciences #FGFR_Biology #ASCO_GU

Tyra Biosciences Set to Engage Investors at Major Conferences in November and December 2025 Tyra Biosciences announces participation in significant upcoming investor conferences in London and New York, showcasing its groundbreaking precision medicines and innovative pipeline.

Tyra Biosciences Set to Engage Investors at Major Conferences in November and December 2025 #USA #Precision_Medicine #Carlsbad #Tyra_Biosciences #FGFR_Biology

Tyra Biosciences Releases Q2 2025 Financial Results and Key Developments Tyra Biosciences shares its financial results for Q2 2025, including advancements in cancer treatment research and ongoing clinical trials.

Tyra Biosciences Releases Q2 2025 Financial Results and Key Developments #United_States #Carlsbad #Tyra_Biosciences #FGFR_Biology #Dabogratinib

Tyra Biosciences Unveils Promising 2024 Financial Results and Research Advancements Tyra Biosciences has reported its financial results for 2024, highlighting significant developments in oncology treatments and advancements in clinical trials.

Tyra Biosciences Unveils Promising 2024 Financial Results and Research Advancements #USA #Carlsbad #Tyra_Biosciences #TYRA-300 #FGFR_Biology

Adele Gulfo Joins Tyra Biosciences Board, Bringing Vast Drug Development Experience Tyra Biosciences, Inc. welcomes Adele Gulfo to its Board of Directors. With nearly three decades in drug commercialization, her expertise will be invaluable.

Adele Gulfo Joins Tyra Biosciences Board, Bringing Vast Drug Development Experience #USA #Carlsbad,_California #Tyra_Biosciences #Adele_Gulfo #FGFR_Biology